CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Sunitinib

Last Updated: July 20, 2006
Result type: Reports
Project Number: S0069
Product Line: Common Drug Review

Generic Name: Sunitinib

Brand Name: Sutent

Manufacturer: Pfizer Canada Inc.

Indications: Gastrointestinal stromal tumour (GIST)

Submission Type: New

Project Status: Complete

Date Recommendation Issued: March 28, 2007

Recommendation Type: List with clinical criteria and/or conditions